Added to YB: 2024-08-23
Pitch date: 2024-08-14
MEDP [bullish]
Medpace Holdings, Inc.
+27.84%
current return
Author Info
No bio for this author
Company Info
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
Market Cap
$12.8B
Pitch Price
$388.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
20.52
P/E
29.53
EV/Sales
4.92
Sector
Life Sciences Tools and Services
Category
growth
Medpace: investing in an eternal human
MEDP: Leading CRO with 38.9% CAGR since IPO. Comprehensive clinical trial services, strong in oncology. High ROE/ROIC, 100%+ cash conversion. Global expertise, reputation moat. Risks: contract renewals, funding sensitivity. Slightly overvalued but confident in management. Initiated 1/3 position for long-term growth.
Read full article (8 min)